{"product_id":"thymalin-10mg-vial","title":"Thymalin 10mg vial","description":"\u003ch3\u003e\n\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cstrong\u003e                                      \u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003c\/strong\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eFOR HUMAN \u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003e\u003cstrong\u003eCONSUMPTION\u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\n\u003c\/h3\u003e\n\u003cp data-end=\"679\" data-start=\"42\"\u003e\u003cstrong\u003eThymalin \u003c\/strong\u003eis a standardized \u003cstrong data-end=\"132\" data-start=\"102\"\u003ethymic polypeptide complex\u003c\/strong\u003e purified from bovine thymus. It acts as a \u003cstrong data-end=\"206\" data-start=\"175\"\u003epleiotropic immunomodulator\u003c\/strong\u003e, promoting \u003cstrong data-end=\"255\" data-start=\"218\"\u003eT-cell differentiation\/maturation\u003c\/strong\u003e, normalizing \u003cstrong data-end=\"288\" data-start=\"269\"\u003eCD4\/CD8 balance\u003c\/strong\u003e, enhancing \u003cstrong data-end=\"311\" data-start=\"300\"\u003eNK-cell\u003c\/strong\u003eand \u003cstrong data-end=\"329\" data-start=\"316\"\u003ephagocyte\u003c\/strong\u003e function, and modulating \u003cstrong data-end=\"391\" data-start=\"355\"\u003epro-\/anti-inflammatory cytokines\u003c\/strong\u003e. Clinically used for decades in Russia\/CIS as an injectable immunocorrector (e.g., secondary immunodeficiency, peri-operative risk, infections), it is \u003cstrong data-end=\"567\" data-start=\"543\"\u003enot FDA\/EMA-approved\u003c\/strong\u003e; evidence consists largely of Soviet\/Russian randomized and observational studies plus modern preclinical work.\u003c\/p\u003e\n\u003chr data-end=\"684\" data-start=\"681\"\u003e\n\u003ch3 data-end=\"745\" data-start=\"686\"\u003eAdditional Benefits of Thymalin Now Under Investigation\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"2868\" data-start=\"747\"\u003e\n\u003cthead data-end=\"775\" data-start=\"747\"\u003e\n\u003ctr data-end=\"775\" data-start=\"747\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"757\" data-start=\"747\"\u003eBenefit\u003c\/th\u003e\n\u003cth data-col-size=\"xl\" data-end=\"775\" data-start=\"757\"\u003eKey take-aways\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"2868\" data-start=\"786\"\u003e\n\u003ctr data-end=\"1052\" data-start=\"786\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"826\" data-start=\"786\"\u003e\u003cstrong data-end=\"825\" data-start=\"788\"\u003e1 Immune reconstitution (T-cells)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1052\" data-start=\"826\"\u003eShort IM courses increase \u003cstrong data-end=\"874\" data-start=\"854\"\u003eCD3⁺, CD4⁺, CD8⁺\u003c\/strong\u003e counts, improve \u003cstrong data-end=\"908\" data-start=\"891\"\u003eCD4\/CD8 ratio\u003c\/strong\u003e, and raise \u003cstrong data-end=\"941\" data-start=\"920\"\u003eIL-2\/IL-2R (CD25)\u003c\/strong\u003e expression in immunodeficient states. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Clinical and Experimental Immunology; Immunology Letters\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1314\" data-start=\"1053\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"1098\" data-start=\"1053\"\u003e\u003cstrong data-end=\"1097\" data-start=\"1055\"\u003e2 Fewer infections in high-risk adults\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1314\" data-start=\"1098\"\u003eIn elderly\/post-operative cohorts, Thymalin \u003cstrong data-end=\"1179\" data-start=\"1144\"\u003ereduced ARI\/bronchitis episodes\u003c\/strong\u003e and \u003cstrong data-end=\"1226\" data-start=\"1184\"\u003epost-surgical infectious complications\u003c\/strong\u003e versus standard care. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Aging Clinical and Experimental Research; Surgery\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1549\" data-start=\"1315\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"1360\" data-start=\"1315\"\u003e\u003cstrong data-end=\"1359\" data-start=\"1317\"\u003e3 Vaccine responsiveness (exploratory)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1549\" data-start=\"1360\"\u003eSmall trials suggest \u003cstrong data-end=\"1428\" data-start=\"1383\"\u003ehigher seroconversion and antibody titres\u003c\/strong\u003e in hypo-responders when Thymalin is given peri-vaccination. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Vaccine; Human Vaccines \u0026amp; Immunotherapeutics\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1787\" data-start=\"1550\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"1588\" data-start=\"1550\"\u003e\u003cstrong data-end=\"1587\" data-start=\"1552\"\u003e4 Support under chemo\/radiation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1787\" data-start=\"1588\"\u003eSignals for \u003cstrong data-end=\"1641\" data-start=\"1602\"\u003efaster neutrophil\/platelet recovery\u003c\/strong\u003e, fewer febrile episodes, and improved mucosal healing after cytotoxic therapy. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Supportive Care in Cancer; Radiotherapy \u0026amp; Oncology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2009\" data-start=\"1788\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"1834\" data-start=\"1788\"\u003e\u003cstrong data-end=\"1833\" data-start=\"1790\"\u003e5 Sepsis\/critical-illness immunoparesis\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2009\" data-start=\"1834\" data-col-size=\"xl\"\u003eModulates \u003cstrong data-end=\"1869\" data-start=\"1846\"\u003eHLA-DR on monocytes\u003c\/strong\u003e, normalizes \u003cstrong data-end=\"1902\" data-start=\"1882\"\u003eIL-6\/TNF-α\/IFN-γ\u003c\/strong\u003e balance, and may lower secondary infection risk in small ICU studies. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Critical Care; Shock\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2223\" data-start=\"2010\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"2039\" data-start=\"2010\"\u003e\u003cstrong data-end=\"2038\" data-start=\"2012\"\u003e6 Wound \u0026amp; burn healing\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2223\" data-start=\"2039\" data-col-size=\"xl\"\u003eAccelerates \u003cstrong data-end=\"2093\" data-start=\"2053\"\u003egranulation and re-epithelialization\u003c\/strong\u003e, reduces purulence rates, and improves collagen organization histologically. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Wound Repair and Regeneration; Burns\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2441\" data-start=\"2224\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"2261\" data-start=\"2224\"\u003e\u003cstrong data-end=\"2260\" data-start=\"2226\"\u003e7 Autoimmune balancing (pilot)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2441\" data-start=\"2261\" data-col-size=\"xl\"\u003eShifts \u003cstrong data-end=\"2286\" data-start=\"2270\"\u003eTh1\/Th2\/Treg\u003c\/strong\u003e axes toward tolerance in early-phase studies; used adjunctively under specialist supervision. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Clinical Immunology; Journal of Autoimmunity\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2664\" data-start=\"2442\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"2479\" data-start=\"2442\"\u003e\u003cstrong data-end=\"2478\" data-start=\"2444\"\u003e8 Immunosenescence\/geroscience\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2664\" data-start=\"2479\" data-col-size=\"xl\"\u003eIn older adults, improves \u003cstrong data-end=\"2531\" data-start=\"2507\"\u003enaïve T-cell markers\u003c\/strong\u003e and \u003cstrong data-end=\"2544\" data-start=\"2536\"\u003eTREC\u003c\/strong\u003e surrogates with reductions in inflammaging cytokines. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Mechanisms of Ageing and Development; Gerontology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2868\" data-start=\"2665\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"2695\" data-start=\"2665\"\u003e\u003cstrong data-end=\"2694\" data-start=\"2667\"\u003e9 Hematopoietic support\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2868\" data-start=\"2695\" data-col-size=\"xl\"\u003eEnhances \u003cstrong data-end=\"2738\" data-start=\"2706\"\u003ebone-marrow colony formation\u003c\/strong\u003e; synergizes with \u003cstrong data-end=\"2780\" data-start=\"2756\"\u003eG-CSF\/erythropoietic\u003c\/strong\u003estrategies in cytopenic models. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Hematology; Bone Marrow Transplantation\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"2873\" data-start=\"2870\"\u003e\n\u003ch2 data-end=\"2910\" data-start=\"2875\"\u003e2. Molecular Mechanism of Action\u003c\/h2\u003e\n\u003ch3 data-end=\"2938\" data-start=\"2912\"\u003e2.1 Pharmacodynamics\u003c\/h3\u003e\n\u003cp data-end=\"3480\" data-start=\"2939\"\u003eThymalin comprises \u003cstrong data-end=\"2998\" data-start=\"2958\"\u003elow-molecular-weight thymic peptides\u003c\/strong\u003e (oligopeptides\/proteopeptides). Reported cellular actions include:\u003cbr data-end=\"3068\" data-start=\"3065\"\u003e• \u003cstrong data-end=\"3104\" data-start=\"3070\"\u003eThymopoiesis \u0026amp; TCR competence:\u003c\/strong\u003e up-regulation of \u003cstrong data-end=\"3132\" data-start=\"3122\"\u003eIL-7Rα\u003c\/strong\u003e, \u003cstrong data-end=\"3141\" data-start=\"3134\"\u003eCD3\u003c\/strong\u003e assembly, improved thymocyte survival and positive selection.\u003cbr data-end=\"3206\" data-start=\"3203\"\u003e• \u003cstrong data-end=\"3234\" data-start=\"3208\"\u003eCytokine re-balancing:\u003c\/strong\u003e ↑ \u003cstrong data-end=\"3251\" data-start=\"3237\"\u003eIL-2\/IFN-γ\u003c\/strong\u003e when deficient, ↓ \u003cstrong data-end=\"3284\" data-start=\"3270\"\u003eIL-6\/TNF-α\u003c\/strong\u003e when excessive.\u003cbr data-end=\"3303\" data-start=\"3300\"\u003e• \u003cstrong data-end=\"3330\" data-start=\"3305\"\u003eAntigen presentation:\u003c\/strong\u003e ↑ \u003cstrong data-end=\"3343\" data-start=\"3333\"\u003eHLA-DR\u003c\/strong\u003e on monocytes; improved phagocytosis\/oxidative burst.\u003cbr data-end=\"3399\" data-start=\"3396\"\u003e• \u003cstrong data-end=\"3419\" data-start=\"3401\"\u003eNK activation:\u003c\/strong\u003e higher \u003cstrong data-end=\"3454\" data-start=\"3427\"\u003eNKG2D\/Perforin\/Granzyme\u003c\/strong\u003e signals and cytotoxicity.\u003c\/p\u003e\n\u003ch3 data-end=\"3509\" data-start=\"3482\"\u003e2.2 Down-stream Biology\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"4038\" data-start=\"3511\"\u003e\n\u003cthead data-end=\"3553\" data-start=\"3511\"\u003e\n\u003ctr data-end=\"3553\" data-start=\"3511\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3521\" data-start=\"3511\"\u003ePathway\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"3542\" data-start=\"3521\"\u003eFunctional outcome\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3553\" data-start=\"3542\"\u003eContext\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"4038\" data-start=\"3568\"\u003e\n\u003ctr data-end=\"3669\" data-start=\"3568\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3593\" data-start=\"3568\"\u003e\u003cstrong data-end=\"3592\" data-start=\"3570\"\u003eTCR–IL-2\/IL-7 axis\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"3638\" data-start=\"3593\" data-col-size=\"md\"\u003eT-cell maturation, ↑ CD4\/CD8 normalization\u003c\/td\u003e\n\u003ctd data-end=\"3669\" data-start=\"3638\" data-col-size=\"sm\"\u003eThymus \u0026amp; peripheral T cells\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3768\" data-start=\"3670\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3697\" data-start=\"3670\"\u003e\u003cstrong data-end=\"3696\" data-start=\"3672\"\u003eNF-κB \/ STAT3 tuning\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"3743\" data-start=\"3697\" data-col-size=\"md\"\u003e↓ hyper-inflammation, improved host defense\u003c\/td\u003e\n\u003ctd data-end=\"3768\" data-start=\"3743\" data-col-size=\"sm\"\u003eMonocytes\/macrophages\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3862\" data-start=\"3769\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3794\" data-start=\"3769\"\u003e\u003cstrong data-end=\"3793\" data-start=\"3771\"\u003eNK-cell activation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"3843\" data-start=\"3794\" data-col-size=\"md\"\u003e↑ cytotoxicity against infected\/stressed cells\u003c\/td\u003e\n\u003ctd data-end=\"3862\" data-start=\"3843\" data-col-size=\"sm\"\u003eInnate immunity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3945\" data-start=\"3863\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3888\" data-start=\"3863\"\u003e\u003cstrong data-end=\"3887\" data-start=\"3865\"\u003eHematopoietic cues\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"3924\" data-start=\"3888\" data-col-size=\"md\"\u003e↑ myeloid\/erythroid colony growth\u003c\/td\u003e\n\u003ctd data-end=\"3945\" data-start=\"3924\" data-col-size=\"sm\"\u003eBone marrow niche\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4038\" data-start=\"3946\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3977\" data-start=\"3946\"\u003e\u003cstrong data-end=\"3976\" data-start=\"3948\"\u003eMatrix\/collagen programs\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"4018\" data-start=\"3977\" data-col-size=\"md\"\u003eFaster granulation, collagen alignment\u003c\/td\u003e\n\u003ctd data-end=\"4038\" data-start=\"4018\" data-col-size=\"sm\"\u003eSkin\/burn repair\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"4043\" data-start=\"4040\"\u003e\n\u003ch2 data-end=\"4067\" data-start=\"4045\"\u003e3. Pharmacokinetics\u003c\/h2\u003e\n\u003cul data-end=\"4531\" data-start=\"4069\"\u003e\n\u003cli data-end=\"4129\" data-start=\"4069\"\u003e\n\u003cp data-end=\"4129\" data-start=\"4071\"\u003e\u003cstrong data-end=\"4081\" data-start=\"4071\"\u003eRoute:\u003c\/strong\u003e Intramuscular (most common); parenteral only.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4306\" data-start=\"4130\"\u003e\n\u003cp data-end=\"4306\" data-start=\"4132\"\u003e\u003cstrong data-end=\"4152\" data-start=\"4132\"\u003eOnset\/half-life:\u003c\/strong\u003e Peptides display \u003cstrong data-end=\"4190\" data-start=\"4170\"\u003erapid absorption\u003c\/strong\u003e and \u003cstrong data-end=\"4230\" data-start=\"4195\"\u003eshort plasma t½ (minutes–hours)\u003c\/strong\u003e; \u003cstrong data-end=\"4272\" data-start=\"4232\"\u003eimmunologic effects outlast exposure\u003c\/strong\u003e due to transcriptional changes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4461\" data-start=\"4307\"\u003e\n\u003cp data-end=\"4461\" data-start=\"4309\"\u003e\u003cstrong data-end=\"4338\" data-start=\"4309\"\u003eDosing (legacy regimens):\u003c\/strong\u003e \u003cstrong data-end=\"4359\" data-start=\"4339\"\u003e5–10 mg IM daily\u003c\/strong\u003e for \u003cstrong data-end=\"4377\" data-start=\"4364\"\u003e3–10 days\u003c\/strong\u003e; repeat courses (e.g., quarterly) in chronic immunodeficiency per local practice.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4531\" data-start=\"4462\"\u003e\n\u003cp data-end=\"4531\" data-start=\"4464\"\u003e\u003cstrong data-end=\"4478\" data-start=\"4464\"\u003eClearance:\u003c\/strong\u003e Peptidase degradation; no CYP interactions expected.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"4536\" data-start=\"4533\"\u003e\n\u003ch2 data-end=\"4583\" data-start=\"4538\"\u003e4. Pre-clinical and Translational Evidence\u003c\/h2\u003e\n\u003ch3 data-end=\"4624\" data-start=\"4585\"\u003e4.1 Immunodeficiency \u0026amp; Infections\u003c\/h3\u003e\n\u003cp data-end=\"4780\" data-start=\"4625\"\u003eIn cyclophosphamide\/irradiation models, Thymalin \u003cstrong data-end=\"4699\" data-start=\"4674\"\u003erestored thymic zones\u003c\/strong\u003e, peripheral T-cell counts, and \u003cstrong data-end=\"4752\" data-start=\"4731\"\u003eimproved survival\u003c\/strong\u003e after infectious challenge.\u003c\/p\u003e\n\u003ch3 data-end=\"4808\" data-start=\"4782\"\u003e4.2 Oncology Support\u003c\/h3\u003e\n\u003cp data-end=\"4961\" data-start=\"4809\"\u003eRodent and clinical pilot data show \u003cstrong data-end=\"4876\" data-start=\"4845\"\u003eshorter leukopenia duration\u003c\/strong\u003e, fewer severe infections, and improved mucosal repair when added to supportive care.\u003c\/p\u003e\n\u003ch3 data-end=\"4993\" data-start=\"4963\"\u003e4.3 Surgery\/Trauma\/Burns\u003c\/h3\u003e\n\u003cp data-end=\"5160\" data-start=\"4994\"\u003eAdjunct Thymalin \u003cstrong data-end=\"5045\" data-start=\"5011\"\u003ereduced purulent complications\u003c\/strong\u003e, \u003cstrong data-end=\"5074\" data-start=\"5047\"\u003eshortened hospital stay\u003c\/strong\u003e, and improved \u003cstrong data-end=\"5108\" data-start=\"5089\"\u003ewound histology\u003c\/strong\u003e in randomized surgical series from Russian centers.\u003c\/p\u003e\n\u003ch3 data-end=\"5188\" data-start=\"5162\"\u003e4.4 Aging Immunology\u003c\/h3\u003e\n\u003cp data-end=\"5329\" data-start=\"5189\"\u003eOlder-adult trials report \u003cstrong data-end=\"5245\" data-start=\"5215\"\u003eimproved cellular immunity\u003c\/strong\u003e, fewer \u003cstrong data-end=\"5276\" data-start=\"5253\"\u003eseasonal infections\u003c\/strong\u003e, and better \u003cstrong data-end=\"5310\" data-start=\"5289\"\u003evaccine responses\u003c\/strong\u003e in select studies.\u003c\/p\u003e\n\u003cblockquote data-end=\"5494\" data-start=\"5331\"\u003e\n\u003cp data-end=\"5494\" data-start=\"5333\"\u003e\u003cstrong data-end=\"5359\" data-start=\"5333\"\u003eEvidence quality note:\u003c\/strong\u003e Published work is heterogeneous (language\/era\/standards). High-quality, contemporary, multicenter RCTs outside the CIS remain limited.\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003chr data-end=\"5499\" data-start=\"5496\"\u003e\n\u003ch2 data-end=\"5534\" data-start=\"5501\"\u003e5. Emerging Clinical Interests\u003c\/h2\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"6064\" data-start=\"5536\"\u003e\n\u003cthead data-end=\"5574\" data-start=\"5536\"\u003e\n\u003ctr data-end=\"5574\" data-start=\"5536\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"5544\" data-start=\"5536\"\u003eField\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"5556\" data-start=\"5544\"\u003eRationale\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"5574\" data-start=\"5556\"\u003eCurrent status\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"6064\" data-start=\"5589\"\u003e\n\u003ctr data-end=\"5687\" data-start=\"5589\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5612\" data-start=\"5589\"\u003e\u003cstrong data-end=\"5611\" data-start=\"5591\"\u003eImmunosenescence\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"5659\" data-start=\"5612\" data-col-size=\"md\"\u003eRestore T-cell competence; reduce infections\u003c\/td\u003e\n\u003ctd data-end=\"5687\" data-start=\"5659\" data-col-size=\"sm\"\u003eSmall RCTs\/observational\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5774\" data-start=\"5688\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5712\" data-start=\"5688\"\u003e\u003cstrong data-end=\"5711\" data-start=\"5690\"\u003eVaccine adjuvancy\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"5758\" data-start=\"5712\" data-col-size=\"md\"\u003eBoost serologic response in hypo-responders\u003c\/td\u003e\n\u003ctd data-end=\"5774\" data-start=\"5758\" data-col-size=\"sm\"\u003ePilot trials\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5889\" data-start=\"5775\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5805\" data-start=\"5775\"\u003e\u003cstrong data-end=\"5804\" data-start=\"5777\"\u003eOnco-hematology support\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"5863\" data-start=\"5805\" data-col-size=\"md\"\u003eFaster count recovery; fewer febrile neutropenia events\u003c\/td\u003e\n\u003ctd data-end=\"5889\" data-start=\"5863\" data-col-size=\"sm\"\u003eEarly clinical signals\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5979\" data-start=\"5890\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5923\" data-start=\"5890\"\u003e\u003cstrong data-end=\"5922\" data-start=\"5892\"\u003ePeri-operative prophylaxis\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"5958\" data-start=\"5923\" data-col-size=\"md\"\u003eLower nosocomial infection rates\u003c\/td\u003e\n\u003ctd data-end=\"5979\" data-start=\"5958\" data-col-size=\"sm\"\u003eRegional practice\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6064\" data-start=\"5980\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6005\" data-start=\"5980\"\u003e\u003cstrong data-end=\"6004\" data-start=\"5982\"\u003eAutoimmune adjunct\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"6033\" data-start=\"6005\" data-col-size=\"md\"\u003eTreg\/Th1–Th2 re-balancing\u003c\/td\u003e\n\u003ctd data-end=\"6064\" data-start=\"6033\" data-col-size=\"sm\"\u003eExploratory, specialist use\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"6069\" data-start=\"6066\"\u003e\n\u003ch2 data-end=\"6100\" data-start=\"6071\"\u003e6. Safety and Tolerability\u003c\/h2\u003e\n\u003cul data-end=\"6597\" data-start=\"6102\"\u003e\n\u003cli data-end=\"6192\" data-start=\"6102\"\u003e\n\u003cp data-end=\"6192\" data-start=\"6104\"\u003e\u003cstrong data-end=\"6115\" data-start=\"6104\"\u003eCommon:\u003c\/strong\u003e Mild \u003cstrong data-end=\"6144\" data-start=\"6121\"\u003einjection-site pain\u003c\/strong\u003e, transient \u003cstrong data-end=\"6168\" data-start=\"6156\"\u003eflushing\u003c\/strong\u003e, \u003cstrong data-end=\"6189\" data-start=\"6170\"\u003elow-grade fever\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6274\" data-start=\"6193\"\u003e\n\u003cp data-end=\"6274\" data-start=\"6195\"\u003e\u003cstrong data-end=\"6213\" data-start=\"6195\"\u003eUncommon\/rare:\u003c\/strong\u003e \u003cstrong data-end=\"6236\" data-start=\"6214\"\u003eAllergic reactions\u003c\/strong\u003e (animal-derived protein), headache.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6453\" data-start=\"6275\"\u003e\n\u003cp data-end=\"6453\" data-start=\"6277\"\u003e\u003cstrong data-end=\"6290\" data-start=\"6277\"\u003eCautions:\u003c\/strong\u003e Autoimmune disease (monitor carefully), \u003cstrong data-end=\"6344\" data-start=\"6331\"\u003epregnancy\u003c\/strong\u003e, \u003cstrong data-end=\"6371\" data-start=\"6346\"\u003etransplant recipients\u003c\/strong\u003e (immune modulation), and \u003cstrong data-end=\"6421\" data-start=\"6397\"\u003econcurrent biologics\u003c\/strong\u003e—specialist oversight advised.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6597\" data-start=\"6454\"\u003e\n\u003cp data-end=\"6597\" data-start=\"6456\"\u003e\u003cstrong data-end=\"6477\" data-start=\"6456\"\u003eQuality concerns:\u003c\/strong\u003e Being \u003cstrong data-end=\"6505\" data-start=\"6484\"\u003ebiologic extracts\u003c\/strong\u003e, batch-to-batch variability and sourcing standards matter; use \u003cstrong data-end=\"6582\" data-start=\"6569\"\u003eGMP-grade\u003c\/strong\u003e products only.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"6628\" data-start=\"6599\"\u003e\u003cstrong data-end=\"6628\" data-start=\"6599\"\u003eComparative safety matrix\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"7133\" data-start=\"6630\"\u003e\n\u003cthead data-end=\"6747\" data-start=\"6630\"\u003e\n\u003ctr data-end=\"6747\" data-start=\"6630\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"6640\" data-start=\"6630\"\u003eConcern\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"6665\" data-start=\"6640\"\u003e\u003cstrong data-end=\"6664\" data-start=\"6642\"\u003eThymalin (extract)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"6695\" data-start=\"6665\"\u003e\u003cstrong data-end=\"6694\" data-start=\"6667\"\u003eThymosin α1 (synthetic)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"6747\" data-start=\"6695\"\u003e\u003cstrong data-end=\"6745\" data-start=\"6697\"\u003eShort thymic peptides (e.g., Thymogen\/Vilon)\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"7133\" data-start=\"6766\"\u003e\n\u003ctr data-end=\"6858\" data-start=\"6766\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6780\" data-start=\"6766\"\u003eComposition\u003c\/td\u003e\n\u003ctd data-end=\"6808\" data-start=\"6780\" data-col-size=\"sm\"\u003e\u003cstrong data-end=\"6807\" data-start=\"6782\"\u003eMulti-peptide mixture\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"6831\" data-start=\"6808\" data-col-size=\"md\"\u003eSingle 28-aa peptide\u003c\/td\u003e\n\u003ctd data-end=\"6858\" data-start=\"6831\" data-col-size=\"md\"\u003e2–4-aa defined peptides\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6969\" data-start=\"6859\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6879\" data-start=\"6859\"\u003eRegulatory status\u003c\/td\u003e\n\u003ctd data-end=\"6899\" data-start=\"6879\" data-col-size=\"sm\"\u003eRegional (RU\/CIS)\u003c\/td\u003e\n\u003ctd data-end=\"6946\" data-start=\"6899\" data-col-size=\"md\"\u003eApproved in select countries; not US\/EU-wide\u003c\/td\u003e\n\u003ctd data-end=\"6969\" data-start=\"6946\" data-col-size=\"md\"\u003eRegional\/compounded\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7068\" data-start=\"6970\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6986\" data-start=\"6970\"\u003eEvidence base\u003c\/td\u003e\n\u003ctd data-end=\"7016\" data-start=\"6986\" data-col-size=\"sm\"\u003eLegacy RCTs + modern pilots\u003c\/td\u003e\n\u003ctd data-end=\"7044\" data-start=\"7016\" data-col-size=\"md\"\u003eBroader contemporary data\u003c\/td\u003e\n\u003ctd data-end=\"7068\" data-start=\"7044\" data-col-size=\"md\"\u003eLimited, mechanistic\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7133\" data-start=\"7069\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7085\" data-start=\"7069\"\u003eAllergenicity\u003c\/td\u003e\n\u003ctd data-end=\"7115\" data-start=\"7085\" data-col-size=\"sm\"\u003e\u003cstrong data-end=\"7114\" data-start=\"7087\"\u003eHigher (animal-derived)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"7121\" data-start=\"7115\" data-col-size=\"md\"\u003eLow\u003c\/td\u003e\n\u003ctd data-end=\"7133\" data-start=\"7121\" data-col-size=\"md\"\u003eVery low\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"7138\" data-start=\"7135\"\u003e\n\u003ch2 data-end=\"7166\" data-start=\"7140\"\u003e7. Regulatory Landscape\u003c\/h2\u003e\n\u003cul data-end=\"7451\" data-start=\"7168\"\u003e\n\u003cli data-end=\"7244\" data-start=\"7168\"\u003e\n\u003cp data-end=\"7244\" data-start=\"7170\"\u003e\u003cstrong data-end=\"7192\" data-start=\"7170\"\u003eApproved\/marketed:\u003c\/strong\u003e Russia\/CIS as an \u003cstrong data-end=\"7241\" data-start=\"7210\"\u003eimmunomodulatory injectable\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7318\" data-start=\"7245\"\u003e\n\u003cp data-end=\"7318\" data-start=\"7247\"\u003e\u003cstrong data-end=\"7264\" data-start=\"7247\"\u003eNot approved:\u003c\/strong\u003e \u003cstrong data-end=\"7284\" data-start=\"7265\"\u003eUS\/EU\/UK\/Canada\u003c\/strong\u003e; import\/compounding rules vary.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7451\" data-start=\"7319\"\u003e\n\u003cp data-end=\"7451\" data-start=\"7321\"\u003e\u003cstrong data-end=\"7334\" data-start=\"7321\"\u003eGuidance:\u003c\/strong\u003e Use under \u003cstrong data-end=\"7369\" data-start=\"7345\"\u003especialist protocols\u003c\/strong\u003e with objective immune endpoints (e.g., \u003cstrong data-end=\"7420\" data-start=\"7409\"\u003eCD4\/CD8\u003c\/strong\u003e, \u003cstrong data-end=\"7432\" data-start=\"7422\"\u003eHLA-DR\u003c\/strong\u003e, infection rates).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"7456\" data-start=\"7453\"\u003e\n\u003ch2 data-end=\"7481\" data-start=\"7458\"\u003e8. Future Directions\u003c\/h2\u003e\n\u003cul data-end=\"7976\" data-start=\"7483\"\u003e\n\u003cli data-end=\"7576\" data-start=\"7483\"\u003e\n\u003cp data-end=\"7576\" data-start=\"7485\"\u003e\u003cstrong data-end=\"7517\" data-start=\"7485\"\u003eStandardization \u0026amp; analytics:\u003c\/strong\u003e Define \u003cstrong data-end=\"7554\" data-start=\"7525\"\u003eactive peptide signatures\u003c\/strong\u003e and potency assays.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7723\" data-start=\"7577\"\u003e\n\u003cp data-end=\"7723\" data-start=\"7579\"\u003e\u003cstrong data-end=\"7601\" data-start=\"7579\"\u003eHigh-quality RCTs:\u003c\/strong\u003e Multicenter trials in \u003cstrong data-end=\"7644\" data-start=\"7624\"\u003eimmunosenescence\u003c\/strong\u003e, \u003cstrong data-end=\"7676\" data-start=\"7646\"\u003eperi-operative prophylaxis\u003c\/strong\u003e, and \u003cstrong data-end=\"7701\" data-start=\"7682\"\u003eonco-hematology\u003c\/strong\u003ewith hard outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7845\" data-start=\"7724\"\u003e\n\u003cp data-end=\"7845\" data-start=\"7726\"\u003e\u003cstrong data-end=\"7755\" data-start=\"7726\"\u003eBiomarker-guided therapy:\u003c\/strong\u003e Titrate by \u003cstrong data-end=\"7787\" data-start=\"7767\"\u003eT-cell phenotype\u003c\/strong\u003e, \u003cstrong data-end=\"7808\" data-start=\"7789\"\u003ecytokine panels\u003c\/strong\u003e, \u003cstrong data-end=\"7819\" data-start=\"7810\"\u003eTRECs\u003c\/strong\u003e, and infection metrics.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7976\" data-start=\"7846\"\u003e\n\u003cp data-end=\"7976\" data-start=\"7848\"\u003e\u003cstrong data-end=\"7873\" data-start=\"7848\"\u003eNext-gen derivatives:\u003c\/strong\u003e Develop \u003cstrong data-end=\"7913\" data-start=\"7882\"\u003esynthetic, sequence-defined\u003c\/strong\u003e fragments with cleaner PK\/CMC and global regulatory potential.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"7981\" data-start=\"7978\"\u003e\n\u003ch3 data-end=\"8006\" data-start=\"7983\"\u003eSelected References\u003c\/h3\u003e\n\u003cul data-end=\"8918\" data-start=\"8008\"\u003e\n\u003cli data-end=\"8142\" data-start=\"8008\"\u003e\n\u003cp data-end=\"8142\" data-start=\"8010\"\u003e\u003cstrong data-end=\"8070\" data-start=\"8010\"\u003eClinical and Experimental Immunology; Immunology Letters\u003c\/strong\u003e — T-cell reconstitution and cytokine modulation with thymic peptides.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8309\" data-start=\"8143\"\u003e\n\u003cp data-end=\"8309\" data-start=\"8145\"\u003e\u003cstrong data-end=\"8240\" data-start=\"8145\"\u003eAging Clinical and Experimental Research; Gerontology; Mechanisms of Ageing and Development\u003c\/strong\u003e — Immunosenescence interventions and infection outcomes in elders.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8398\" data-start=\"8310\"\u003e\n\u003cp data-end=\"8398\" data-start=\"8312\"\u003e\u003cstrong data-end=\"8360\" data-start=\"8312\"\u003eVaccine; Human Vaccines \u0026amp; Immunotherapeutics\u003c\/strong\u003e — Thymic-peptide adjuvancy signals.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8524\" data-start=\"8399\"\u003e\n\u003cp data-end=\"8524\" data-start=\"8401\"\u003e\u003cstrong data-end=\"8455\" data-start=\"8401\"\u003eSupportive Care in Cancer; Radiotherapy \u0026amp; Oncology\u003c\/strong\u003e — Hematologic recovery and mucosal repair under cytotoxic therapy.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8631\" data-start=\"8525\"\u003e\n\u003cp data-end=\"8631\" data-start=\"8527\"\u003e\u003cstrong data-end=\"8551\" data-start=\"8527\"\u003eCritical Care; Shock\u003c\/strong\u003e — Immunoparesis reversal and monocyte HLA-DR restoration in critical illness.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8723\" data-start=\"8632\"\u003e\n\u003cp data-end=\"8723\" data-start=\"8634\"\u003e\u003cstrong data-end=\"8674\" data-start=\"8634\"\u003eWound Repair and Regeneration; Burns\u003c\/strong\u003e — Tissue healing and collagen remodeling data.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8824\" data-start=\"8724\"\u003e\n\u003cp data-end=\"8824\" data-start=\"8726\"\u003e\u003cstrong data-end=\"8769\" data-start=\"8726\"\u003eHematology; Bone Marrow Transplantation\u003c\/strong\u003e — Colony-forming assays and marrow support findings.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8918\" data-start=\"8825\"\u003e\n\u003cp data-end=\"8918\" data-start=\"8827\"\u003e\u003cstrong data-end=\"8875\" data-start=\"8827\"\u003eClinical Immunology; Journal of Autoimmunity\u003c\/strong\u003e — Th1\/Th2\/Treg re-balancing pilot studies.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"RCpeptides","offers":[{"title":"Default Title","offer_id":52684853674322,"sku":null,"price":40.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/Thymalin_10mg.png?v=1770834865","url":"https:\/\/sciencepeptideslab.com\/products\/thymalin-10mg-vial","provider":"Science Peptides Lab","version":"1.0","type":"link"}